IVACC — Intervacc AB Share News
0.000.00%
Last trade - 00:00- SEK443.06m
- SEK297.43m
- SEK20.09m
Brief: Intervacc Elects Emil Billbäck As Chairperson Of Board
Brief: Intervacc Q1 Net Sales Down At SEK 3.4 Million
Brief: Intervacc: Strangvac Vaccine Approved In Iceland
Brief: Intervacc Proposes No Dividend
Brief: Intervacc Announces Change Of CEO
Brief: Intervacc Q3 Net Sales Up At SEK 5.4 Mln
Brief: Intervacc And Dechra Extend Distribution Agreement
Brief: Intervacc Q2 Operating Loss SEK 18.6 Mln
Brief: Intervacc Q1 Net Sales Up At Sek 4.6 Mln
Brief: Intervacc Says Variation Application Previously Submitted To EMA Has Now Been Approved
Brief: Intervacc Q4 Net Sales SEK 4.13 Million
Brief: Intervacc Gets Orders From Dechra Pharmaceuticals
Brief: Intervacc Resolves On Rights Issue Of Approx. Sek 225 Mln
Brief: Intervacc Says Out-Of-Stock Situation Regarding Strangvac In Sweden Resolved
Brief: Intervacc Says Co Identifies A Potential Short Out-Of-Stock Situation Regarding Strangvac
Brief: Intervacc Announces Extended Patent Protection Approved In The UK
Brief: Intervacc Q2 Net Sales At SEK 2.735 Mln
Brief: Intervacc, Karolinska Institutet Extend Contract For Development Of Vaccines
Brief: Intervacc Q1 Operating Loss Widens To SEK 18 Mln